TY  - JOUR
A1  - Thong, Melissa S. Y.
A1  - Doege, Daniela
A1  - Weißer, Linda
A1  - Koch-Gallenkamp, Lena
A1  - Jansen, Lina
A1  - Bertram, Heike
A1  - Eberle, Andrea
A1  - Holleczek, Bernd
A1  - Nennecke, Alice
A1  - Waldmann, Annika
A1  - Zeissig, Sylke Ruth
A1  - Brenner, Hermann
A1  - Arndt, Volker
T1  - Persisting deficits in health-related quality of life of colorectal cancer survivors 14–24 years post-diagnosis: a population-based study
JF  - Current Oncology
N2  - (1) Background: The health-related quality of life (HRQOL) of colorectal cancer (CRC) survivors >10 years post-diagnosis is understudied. We aimed to compare the HRQOL of CRC survivors 14–24 years post-diagnosis to that of age- and sex-matched non-cancer controls, stratified by demographic and clinical factors. (2) Methods: We used data from 506 long-term CRC survivors and 1489 controls recruited from German population-based multi-regional studies. HRQOL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Core-30 (EORTC QLQ-C30) questionnaire. We estimated differences in the HRQOL of CRC survivors and controls with multiple regression, adjusted for age at survey, sex, and education, where appropriate. (3) Results: CRC survivors reported poorer social functioning but better health status/QOL than controls. CRC survivors, in general, had higher levels of symptom burden, and in particular diarrhea and constipation, regardless of demographic or clinical factors. In stratified analyses, HRQOL differed by age, sex, cancer type, and having a permanent stoma. (4) Conclusions: Although CRC survivors may have a comparable health status/QOL to controls 14–24 years after diagnosis, they still live with persistent bowel dysfunction that can negatively impact aspects of functioning. Healthcare providers should provide timely and adapted follow-up care to ameliorate potential long-term suffering.
KW  - colorectal cancer
KW  - long-term survivors
KW  - health-related quality of life
KW  - population-based
KW  - non-cancer controls
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-311084
SN  - 1718-7729
VL  - 30
IS  - 3
SP  - 3373
EP  - 3390
ER  -